Da Pieve Lucia, Collazzo Raffaele, Masutti Monica, De Paoli Paolo
Clinical Risk Management and Accreditation Unit, Centro di Riferimento Oncologico (CRO), IRCCS, National Cancer Institute, Aviano (Pordenone) - Italy.
Scientific Directorate, Centro di Riferimento Oncologico (CRO), IRCCS, National Cancer Institute, Aviano (Pordenone) - Italy.
Tumori. 2015;101 Suppl 1:S10-3. doi: 10.5301/tj.5000456. Epub 2015 Dec 30.
In 2012, the "Centro di Riferimento Oncologico" (CRO) National Cancer Institute joined the accreditation program of the Organisation of European Cancer Institutes (OECI) and was one of the first institutes in Italy to receive recognition as a Comprehensive Cancer Center. At the end of the project, a strengths, weaknesses, opportunities, and threats (SWOT) analysis aimed at identifying the pros and cons, both for the institute and of the accreditation model in general, was performed. The analysis shows significant strengths, such as the affinity with other improvement systems and current regulations, and the focus on a multidisciplinary approach. The proposed suggestions for improvement concern mainly the structure of the standards and aim to facilitate the assessment, benchmarking, and sharing of best practices. The OECI accreditation model provided a valuable executive tool and a framework in which we can identify several important development projects. An additional impact for our institute is the participation in the project BenchCan, of which the OECI is lead partner.
2012年,“国家肿瘤参考中心”(CRO)国家癌症研究所加入了欧洲癌症研究所组织(OECI)的认证计划,是意大利首批获得综合癌症中心认可的机构之一。在项目结束时,进行了优势、劣势、机会和威胁(SWOT)分析,旨在确定该机构以及总体认证模式的利弊。分析显示出显著优势,如与其他改进系统和现行法规的契合度,以及对多学科方法的关注。提出的改进建议主要涉及标准结构,旨在促进最佳实践的评估、对标和分享。OECI认证模式提供了一个有价值的执行工具和一个框架,我们可以在其中确定几个重要的发展项目。对我们机构的另一个影响是参与了BenchCan项目,OECI是该项目的牵头合作伙伴。